Clearpoint Neuro is trading 10.11% up at $10.67; available reporting has not identified a confirmed company-specific catalyst. - Third-quarter results are scheduled for release after the market close, with an investor call at 4:30 p.m. ET; the pending report is context, not a confirmed explanation for the move. - Major U.S. indexes were up less than 0.5%, so broad-market strength does not clearly account for the gain.